Loss of imprinting of IGF2 resulting in increased expression of IGF-2 is a common genetic alteration in human malignancies and aberrant methylation of IGF2/H19 locus has been detected in multiple human cancers including breast cancer [29-31]. The gene discussed is H19; the disease is breast carcinoma.